FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEMIEUX, K.
Right arrow Articles by MARETTE, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEMIEUX, K.
Right arrow Articles by MARETTE, A.
(The FASEB Journal. 2003;17:1658-1665.)
© 2003 FASEB

The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases {alpha} and ß in skeletal muscle

KATHLEEN LEMIEUX*,1, DANIEL KONRAD{dagger},1, AMIRA KLIP{dagger} and ANDRÉ MARETTE*,2

* Department of Anatomy and Physiology, Lipid Research Unit, Laval University Hospital Research Center, Ste-Foy, Québec, G1V 4G2, Canada; and
{dagger} Programme in Cell Biology, Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada

2Correspondence: Department of Physiology and Lipid Research Unit, Laval University Hospital Research Center, 2705, Laurier Bld, Ste-Foy, (Québec), Canada, G1V 4G2. E-mail: andre.marette{at}crchul.ulaval.ca

The AMP-activated protein kinase (AMPK) pathway participates in the metabolic effects of contraction on muscle glucose uptake. We have shown that contraction increases both GLUT4 translocation to the cell surface and p38 mitogen-activated protein kinase (p38 MAPK) activity. The latter pathway may be involved in the activation of GLUT4. Here we investigated whether the AMPK activator AICAR increases glucose uptake by inducing translocation of GLUT4 and/or by activating the p38 MAPK pathway. AICAR infusion into glucose-clamped rats increased muscle glucose uptake and GLUT4 translocation from an intracellular fraction to the plasma membrane but not to T-tubules. AICAR also caused recruitment of the transferrin receptor to the plasma membrane and increased [125I]-transferrin uptake in isolated muscle. AICAR treatment in vivo or in vitro activated both p38 MAPK{alpha} and ß (1.6- to 2.8-fold) in EDL muscles with a time course identical to that of stimulation of AMPK and glucose transport. The p38 MAPK inhibitor SB203580 abrogated the stimulatory effect of AICAR on glucose uptake. These results suggest that AICAR increases muscle glucose uptake by two mechanisms: 1) inducing selective recruitment of GLUT4 to the plasma membrane, and 2) activating p38 MAPK{alpha} and ß, which may be involved in the activation of GLUT4—Lemieux, K., Konrad, D., Klip, A., Marette, A. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases {alpha} and ß in skeletal muscle.—Lemieux, K., Konrad, D., Klip, A., Marette, A. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake via p38 mitogen-activated protein kinases {alpha} and ß in skeletal muscle.


Key Words: glucose transport • exercise • contraction • insulin • plasma membrane




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Mukwevho, T. A. Kohn, D. Lang, E. Nyatia, J. Smith, and E. O. Ojuka
Caffeine induces hyperacetylation of histones at the MEF2 site on the Glut4 promoter and increases MEF2A binding to the site via a CaMK-dependent mechanism
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E582 - E588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. E. Brown, M. Elstner, S. J. Yeaman, D. M. Turnbull, and M. Walker
Does impaired mitochondrial function affect insulin signaling and action in cultured human skeletal muscle cells?
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E97 - E102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Zheng, A. Perianayagam, D. H. Lee, M. D. Brannan, L. E. Yang, D. Tellalian, P. Chen, K. Lemieux, A. Marette, J. H. Youn, et al.
AMPK activation with AICAR provokes an acute fall in plasma [K+]
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C126 - C135.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M. N. Galardo, M. F. Riera, E. H. Pellizzari, S. B. Cigorraga, and S. B. Meroni
The AMP-activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-b-D-ribonucleoside, regulates lactate production in rat Sertoli cells
J. Mol. Endocrinol., October 1, 2007; 39(4): 279 - 288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Pelletier and L. Coderre
Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1325 - E1332.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. S. Jaswal, M. Gandhi, B. A. Finegan, J. R. B. Dyck, and A. S. Clanachan
p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5'-AMP-activated protein kinase
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1978 - H1985.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. LaRosa and S. M. Downs
Meiotic Induction by Heat Stress in Mouse Oocytes: Involvement of AMP-Activated Protein Kinase and MAPK Family Members
Biol Reprod, March 1, 2007; 76(3): 476 - 486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M.-J. Lee, D. Feliers, M. M. Mariappan, K. Sataranatarajan, L. Mahimainathan, N. Musi, M. Foretz, B. Viollet, J. M. Weinberg, G. G. Choudhury, et al.
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F617 - F627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Bhalla, N. M. Oyster, A. C. Fitch, M. A. Wijngaarden, D. Neumann, U. Schlattner, D. Pearce, and K. R. Hallows
AMP-activated Kinase Inhibits the Epithelial Na+ Channel through Functional Regulation of the Ubiquitin Ligase Nedd4-2
J. Biol. Chem., September 8, 2006; 281(36): 26159 - 26169.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. J. Yoon, G. Y. Lee, J.-J. Chung, Y. H. Ahn, S. H. Hong, and J. B. Kim
Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-Activated Protein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator-Activated Receptor {alpha}
Diabetes, September 1, 2006; 55(9): 2562 - 2570.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. T. Treebak, S. Glund, A. Deshmukh, D. K. Klein, Y. C. Long, T. E. Jensen, S. B. Jorgensen, B. Viollet, L. Andersson, D. Neumann, et al.
AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits.
Diabetes, July 1, 2006; 55(7): 2051 - 2058.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. Nilsson, Y. C. Long, S. Martinsson, S. Glund, P. Garcia-Roves, L. T. Svensson, L. Andersson, J. R. Zierath, and M. Mahlapuu
Opposite Transcriptional Regulation in Skeletal Muscle of AMP-activated Protein Kinase {gamma}3 R225Q Transgenic Versus Knock-out Mice
J. Biol. Chem., March 17, 2006; 281(11): 7244 - 7252.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Talukdar, W. Szeszel-Fedorowicz, and L. M. Salati
Arachidonic Acid Inhibits the Insulin Induction of Glucose-6-phosphate Dehydrogenase via p38 MAP Kinase
J. Biol. Chem., December 9, 2005; 280(49): 40660 - 40667.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Li, E. J. Miller, J. Ninomiya-Tsuji, R. R. Russell III, and L. H. Young
AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart
Circ. Res., October 28, 2005; 97(9): 872 - 879.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Yamaguchi, H. Katahira, S. Ozawa, Y. Nakamichi, T. Tanaka, T. Shimoyama, K. Takahashi, K. Yoshimoto, M. O. Imaizumi, S. Nagamatsu, et al.
Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E643 - E649.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Carattino, R. S. Edinger, H. J. Grieser, R. Wise, D. Neumann, U. Schlattner, J. P. Johnson, T. R. Kleyman, and K. R. Hallows
Epithelial Sodium Channel Inhibition by AMP-activated Protein Kinase in Oocytes and Polarized Renal Epithelial Cells
J. Biol. Chem., May 6, 2005; 280(18): 17608 - 17616.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Pelletier, E. Joly, M. Prentki, and L. Coderre
Adenosine 5'-Monophosphate-Activated Protein Kinase and p38 Mitogen-Activated Protein Kinase Participate in the Stimulation of Glucose Uptake by Dinitrophenol in Adult Cardiomyocytes
Endocrinology, May 1, 2005; 146(5): 2285 - 2294.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Ouchi, R. Shibata, and K. Walsh
AMP-Activated Protein Kinase Signaling Stimulates VEGF Expression and Angiogenesis in Skeletal Muscle
Circ. Res., April 29, 2005; 96(8): 838 - 846.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sadagurski, G. Weingarten, C. J. Rhodes, M. F. White, and E. Wertheimer
Insulin Receptor Substrate 2 Plays Diverse Cell-specific Roles in the Regulation of Glucose Transport
J. Biol. Chem., April 15, 2005; 280(15): 14536 - 14544.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Ribe, J. Yang, S. Patel, F. Koumanov, S. W. Cushman, and G. D. Holman
Endofacial Competitive Inhibition of Glucose Transporter-4 Intrinsic Activity by the Mitogen-Activated Protein Kinase Inhibitor SB203580
Endocrinology, April 1, 2005; 146(4): 1713 - 1717.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Shearer, P. T. Fueger, J. N. Rottman, D. P. Bracy, P. H. Martin, and D. H. Wasserman
AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E871 - E877.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Al-Khalili, A. Krook, J. R. Zierath, and G. D. Cartee
Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E553 - E557.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. A. Iglesias, S. M. Furler, G. J. Cooney, E. W. Kraegen, and J.-M. Ye
AMP-Activated Protein Kinase Activation by AICAR Increases Both Muscle Fatty Acid and Glucose Uptake in White Muscle of Insulin-Resistant Rats In Vivo
Diabetes, July 1, 2004; 53(7): 1649 - 1654.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The Federation of American Societies for Experimental Biology.